Compare · RVLP vs ZOM
RVLP vs ZOM
Side-by-side comparison of RVL Pharmaceuticals plc (RVLP) and Zomedica Corp. (ZOM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RVLP and ZOM operate in Pharmaceuticals and Biotechnology (Health Care), so they compete in similar markets.
- ZOM is the larger of the two at $284.2M, about 3.2x RVLP ($90.0M).
- RVLP has more recent analyst coverage (2 ratings vs 1 for ZOM).
- Company
- RVL Pharmaceuticals plc
- Zomedica Corp.
- Price
- $0.03-29.51%
- $0.10-3.15%
- Market cap
- $90.0M
- $284.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Pharmaceuticals and Biotechnology
- Pharmaceuticals and Biotechnology
- Exchange
- NASDAQ
- AMEX
- IPO
- 2018
- 2017
- News (4w)
- 0
- 0
- Recent ratings
- 2
- 1
RVL Pharmaceuticals plc
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
Zomedica Corp.
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA, a diagnostic biosensor platform for the detection of thyroid disorders in dogs and cats, and adrenal disorders in dogs. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.
Latest RVLP
- RVL Pharmaceuticals plc filed SEC Form 8-K: Other Events
- RVL Pharmaceuticals plc filed SEC Form 8-K: Other Events
- RVL Pharmaceuticals plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form SC 13D/A filed by RVL Pharmaceuticals plc (Amendment)
- RVL Pharmaceuticals plc filed SEC Form 8-K: Bankruptcy or Receivership, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits
- SEC Form 25-NSE filed by RVL Pharmaceuticals plc
- SEC Form DEF 14A filed by RVL Pharmaceuticals plc
- SEC Form PRE 14A filed by RVL Pharmaceuticals plc
- RVL Pharmaceuticals plc filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form SC 13D/A filed by RVL Pharmaceuticals plc (Amendment)
Latest ZOM
- Diality Appoints Peter Donato as Chief Financial Officer
- Zomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film Merv
- Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
- Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
- Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential
- Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
- Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
- Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union
- Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar
- Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay